Clover Health Investments, Corp.

NasdaqGS:CLOV 株式レポート

時価総額：US$1.7b

Clover Health Investments マネジメント

マネジメント 基準チェック /34

Clover Health Investmentsの CEO はAndrew Toyで、 Jan2023年に任命され、 の在任期間は 1.83年です。 の年間総報酬は$ 10.15Mで、 6.9%給与と93.1%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.61%を直接所有しており、その価値は$ 10.69M 。経営陣と取締役会の平均在任期間はそれぞれ2.3年と3.7年です。

主要情報

Andrew Toy

最高経営責任者

US$10.2m

報酬総額

CEO給与比率6.9%
CEO在任期間1.8yrs
CEOの所有権0.6%
経営陣の平均在職期間2.3yrs
取締役会の平均在任期間3.7yrs

経営陣の近況

Recent updates

Clover Health: Buy The Dip, Reap The Rewards

Nov 18

Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Nov 08
Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Clover Health's Rally: The Payoff Of A Profitable Pivot

Nov 06

There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Oct 03
There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Clover Health: Changing Business Model, Seeking Profitability

Oct 03

Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success

Aug 15

Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Aug 14
Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Aug 06
Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jun 12
Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Apr 20
Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Mar 16
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Mar 06
Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Clover Health: Its Luck May Have Ran Out

Feb 26

Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Nov 21
Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Jul 07
We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Chamath Palihapitiya-linked Clover Health Investments trading near all-time low

Oct 14

Chamath Palihapitiya cuts stake in Clover Health to under 5%

Oct 04

Rethinking My Clover Health Position

Sep 12

Clover Paid The Price Of Its Alleged Lies; Time To Move On

Aug 17

Clover Health Investments to name president Andrew Toy as CEO

Aug 08

Clover Health Is A Buy Ahead Of Earnings

Jul 29

Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2

Jul 15

Is Clover Health A Good Healthcare Sector Stock Pick?

Jun 30

CEO報酬分析

Clover Health Investments の収益と比較して、Andrew Toy の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$96m

Jun 30 2024n/an/a

-US$121m

Mar 31 2024n/an/a

-US$157m

Dec 31 2023US$10mUS$700k

-US$213m

Sep 30 2023n/an/a

-US$226m

Jun 30 2023n/an/a

-US$268m

Mar 31 2023n/an/a

-US$344m

Dec 31 2022US$10mUS$500k

-US$340m

Sep 30 2022n/an/a

-US$443m

Jun 30 2022n/an/a

-US$402m

Mar 31 2022n/an/a

-US$615m

Dec 31 2021US$142mUS$450k

-US$588m

Sep 30 2021n/an/a

-US$527m

Jun 30 2021n/an/a

-US$487m

Mar 31 2021n/an/a

-US$160m

Dec 31 2020US$9mUS$415k

-US$136m

Sep 30 2020n/an/a

-US$89m

Jun 30 2020n/an/a

-US$145m

Mar 31 2020n/an/a

-US$272m

Dec 31 2019US$424kUS$400k

-US$364m

報酬と市場: Andrewの 総報酬 ($USD 10.15M ) は、 US市場 ($USD 5.57M ) の同規模の企業の平均を上回っています。

報酬と収益: Andrewの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Andrew Toy (45 yo)

1.8yrs

在職期間

US$10,154,701

報酬

Mr. Andrew Toy Co-founded Clover Health Investments, Corp. and serves as its Director since November 2018 and served as its President since March 2019. He serves as Chief Executive Officer at Clover Health...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Vivek Garipalli
Co-Founder & Executive Chairman10.3yrsデータなし18.01%
$ 314.9m
Andrew Toy
Co-Founder1.8yrsUS$10.15m0.61%
$ 10.7m
Karen Soares
General Counsel1.1yrsUS$1.47m0.28%
$ 4.9m
Brady Priest
Chief Executive Officer of Home Care2.3yrsUS$1.35m0.16%
$ 2.8m
Jamie Reynoso
Chief Executive Officer of Medicare Advantage1.8yrsUS$2.49m0.26%
$ 4.5m
Peter Kuipers
Chief Financial Officerless than a yearデータなしデータなし
Conrad Wai
Chief Technology Officer2.8yrsデータなし0.69%
$ 12.1m
Derrick Nueman
Head of Investor Relations & Corporate strategyno dataデータなしデータなし
Wendy Richey
Chief Compliance Officerno dataデータなしデータなし
Rachel Fish
Chief People Officerno dataデータなしデータなし
Kumar Dharmarajan
Chief Medical Officer of Clover Assistant3yrsデータなしデータなし
Mark Spektor
Chief Medical Officer3.8yrsデータなしデータなし

2.3yrs

平均在職期間

46yo

平均年齢

経験豊富な経営陣: CLOVの経営陣は 経験豊富 であると考えられます ( 2.3年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Vivek Garipalli
Co-Founder & Executive Chairman10.3yrsデータなし18.01%
$ 314.9m
Andrew Toy
Co-Founder6yrsUS$10.15m0.61%
$ 10.7m
Lee Shapiro
Independent Director3.8yrsUS$280.93k0.066%
$ 1.2m
Thomas Tran
Directorless than a yearデータなしデータなし
Chelsea Clinton
Independent Director7.8yrsUS$246.55k0.067%
$ 1.2m
Phineas Barnes
Board Observerno dataデータなしデータなし
William Robinson
Independent Director3.7yrsUS$268.43k0.050%
$ 877.6k
Carladenise Edwards
Independent Director2.3yrsUS$250.30k0.041%
$ 719.1k
Anna Loengard
Independent Director2yrsUS$247.80k0.077%
$ 1.3m
Demetrios Kouzoukas
Lead Independent Director3.6yrsUS$320.16k0.044%
$ 776.8k

3.7yrs

平均在職期間

50.5yo

平均年齢

経験豊富なボード: CLOVの 取締役会 は 経験豊富 であると考えられます ( 3.7年の平均在任期間)。